Metastatic hormone-sensitive prostate cancer: clinical decision making in a rapidly evolving landscape of life-prolonging therapy
Authors
VanderWeele, DJAntonarakis, ES
Carducci, MA
Dreicer, R
Fizazi, K
Gillessen, Silke
Higano, CS
Morgans, AK
Petrylak, DP
Sweeney, CJ
Hussain, M
Affiliation
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago,Issue Date
2019
Metadata
Show full item recordCitation
VanderWeele DJ, Antonarakis ES, Carducci MA, Dreicer R, Fizazi K, Gillessen S, et al. Metastatic hormone-sensitive prostate cancer: clinical decision making in a rapidly evolving landscape of life-prolonging therapy. J Clin Oncol. 2019 Sep 10:JCO1901595.Journal
Journal of Clinical OncologyDOI
10.1200/JCO.19.01595PubMed ID
31498754Additional Links
https://dx.doi.org/10.1200/JCO.19.01595Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1200/JCO.19.01595
Scopus Count
Collections
Related articles
- [French CCAFU guidelines on prostate cancer: hormono-naive metastatic prostate cancer - update 2017].
- Authors: Rozet F, Hennequin C, Mongiat-Artus P, Beuzeboc P, Beauval JB, Cormier L, Fromont-Hankard G, Ouzzane A, Ploussard G, Renard-Penna R, Méjean A
- Issue date: 2018 May
- A Framework for Treatment Decision Making at Prostate Cancer Recurrence.
- Authors: Lange JM, Trock BJ, Gulati R, Etzioni R
- Issue date: 2017 Nov
- [The difficult choice: when not to treat. Hormone-refractory metastatic prostate cancer].
- Authors: Bracarda S, Caserta C, Tonato M
- Issue date: 2004 Jul-Aug
- Prostate Cancer Screening-A New Recommendation for Meaningful Physician-Patient Conversations.
- Authors: Misra-Hebert AD, Kattan MW
- Issue date: 2018 Aug 1
- Influence of an International Consensus Conference on Practice Patterns in Advanced Prostate Cancer.
- Authors: Gong J, Omlin A, Pal SK, Hsu J, Tombal B, Sydes MR, Gillessen S
- Issue date: 2018 Aug